MENU

ADVM Stock Tickeron detected bullish Stock Pattern: Three Rising Valleys ADVM on October 03, 2024, netting in a 17.44% gain over 3 weeks

A.I.dvisor
at Tickeron.com
10/19/24
Loading...
+17.44% Gain from a Successful pattern Three Rising Valleys
ADVM - Adverum Biotechnologies
Tickeron
Ticker: ADVM
Company: Adverum Biotechnologies
Gain: +17.44%
Confirmed: 10/03/24
Succeeded: 10/17/24
Total length: 24 days
On September 23, 2024, A.I.dvisor detected a Three Rising Valleys Pattern (Bullish) for Adverum Biotechnologies (ADVM, $6.88). On October 03, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $8.55. 14 days later, on October 17, 2024, ADVM reached the target price resulting in a +1 for traders who took a long position in the stock.

ADVM in upward trend: price rose above 50-day moving average on October 03, 2024

ADVM moved above its 50-day moving average on October 03, 2024 date and that indicates a change from a downward trend to an upward trend. In of 36 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 04, 2024. You may want to consider a long position or call options on ADVM as a result. In of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for ADVM just turned positive on October 03, 2024. Looking at past instances where ADVM's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for ADVM crossed bullishly above the 50-day moving average on October 08, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ADVM advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 146 cases where ADVM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADVM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ADVM broke above its upper Bollinger Band on September 19, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.869) is normal, around the industry mean (12.594). P/E Ratio (0.000) is within average values for comparable stocks, (111.595). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.971). ADVM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (25.000) is also within normal values, averaging (224.025).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ADVM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADVM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
ADVM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of novel gene therapies to treat patients with sight-threatening ophthalmic diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
100 Cardinal Way
Phone
+1 650 659-9323
Employees
121
Web
https://www.adverum.com